Target Price | $495.73 |
Price | $437.08 |
Potential | 13.42% |
Number of Estimates | 11 |
11 Analysts have issued a price target IDEXX Laboratories 2025 . The average IDEXX Laboratories target price is $495.73. This is 13.42% higher than the current stock price. The highest price target is $566.00 29.50% , the lowest is $435.00 0.48% . | |
A rating was issued by 16 analysts: 7 Analysts recommend IDEXX Laboratories to buy, 7 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IDEXX Laboratories stock has an average upside potential 2025 of 13.42% . Most analysts recommend the IDEXX Laboratories stock at Buy or hold. |
11 Analysts have issued a sales forecast IDEXX Laboratories 2024 . The average IDEXX Laboratories sales estimate is $3.9b . This is 0.88% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $3.9b 1.19% , the lowest is $3.9b 0.70% .
This results in the following potential growth metrics:
2023 | $3.7b | 8.72% |
---|---|---|
2024 | $3.9b | 5.95% |
2025 | $4.2b | 7.21% |
2026 | $4.5b | 8.58% |
2027 | $4.9b | 9.34% |
2028 | $5.4b | 9.25% |
8 Analysts have issued an IDEXX Laboratories EBITDA forecast 2024. The average IDEXX Laboratories EBITDA estimate is $1.3b . This is 4.18% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.4b 11.32% , the lowest is $1.2b 0.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $1.2b | 22.17% |
---|---|---|
2024 | $1.3b | 6.83% |
2025 | $1.4b | 10.60% |
2026 | $1.5b | 8.62% |
2027 | $1.7b | 10.48% |
2028 | $1.9b | 9.71% |
2023 | 32.98% | 12.37% |
---|---|---|
2024 | 33.25% | 0.82% |
2025 | 34.31% | 3.19% |
2026 | 34.32% | 0.03% |
2027 | 34.68% | 1.05% |
2028 | 34.82% | 0.40% |
12 IDEXX Laboratories Analysts have issued a net profit forecast 2024. The average IDEXX Laboratories net profit estimate is $858m . This is 0.93% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $864m 1.64% , the lowest is $853m 0.39% .
This results in the following potential growth metrics and future Net Margins:
2023 | $825m | 25.28% |
---|---|---|
2024 | $858m | 3.94% |
2025 | $983m | 14.59% |
2026 | $1.1b | 13.22% |
2027 | $1.3b | 13.39% |
2028 | $1.4b | 10.06% |
2023 | 22.54% | 15.23% |
---|---|---|
2024 | 22.12% | 1.88% |
2025 | 23.64% | 6.87% |
2026 | 24.65% | 4.27% |
2027 | 25.56% | 3.69% |
2028 | 25.75% | 0.74% |
12 Analysts have issued a IDEXX Laboratories forecast for earnings per share. The average IDEXX Laboratories <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $10.46 . This is 0.97% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $10.53 1.64% , the lowest is $10.40 0.39% .
This results in the following potential growth metrics and future valuations:
2023 | $10.06 | 25.28% |
---|---|---|
2024 | $10.46 | 3.98% |
2025 | $11.98 | 14.53% |
2026 | $13.57 | 13.27% |
2027 | $15.38 | 13.34% |
2028 | $16.93 | 10.08% |
Current | 42.91 | 20.84% |
---|---|---|
2024 | 42.53 | 0.89% |
2025 | 37.12 | 12.72% |
2026 | 32.78 | 11.69% |
2027 | 28.91 | 11.81% |
2028 | 26.27 | 9.13% |
Based on analysts' sales estimates for 2024, the IDEXX Laboratories stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 9.57 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 9.39 .
This results in the following potential growth metrics and future valuations:
Current | 9.65 | 22.92% |
---|---|---|
2024 | 9.57 | 0.87% |
2025 | 8.92 | 6.72% |
2026 | 8.22 | 7.90% |
2027 | 7.52 | 8.54% |
2028 | 6.88 | 8.47% |
Current | 9.47 | 22.99% |
---|---|---|
2024 | 9.39 | 0.88% |
2025 | 8.76 | 6.72% |
2026 | 8.07 | 7.90% |
2027 | 7.38 | 8.54% |
2028 | 6.75 | 8.47% |
IDEXX Laboratories...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.